# Cycloserine rTMS Plasticity Augmentation in Depression

> **NCT03511599** · PHASE1 · COMPLETED · sponsor: **University of Calgary** · enrollment: 12 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Cycloserine
- **DEVICE:** Transcranial Magnetic Stimulation
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03511599
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-03
- **Primary completion:** 2020-12-08
- **Final completion:** 2021-04-21
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03511599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03511599, "Cycloserine rTMS Plasticity Augmentation in Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03511599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*